AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 10524634
Drug: UDCA 0
RxNorm normalized name: UDCA
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UDCA 0 mg/day (placebo)
Trial: 20932411
Drug: Cetrorelix pamoate
RxNorm normalized name: Cetrorelix
DrugBank: Cetrorelix (DB00050)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cetrorelix pamoate (various dosages: 30 + 30 mg, 30 + 30 + 30 mg, 60 + 30 mg, 60 + 60 mg)
Trial: 12386644
Drug: High-profile infusion
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-profile infusion (total dose of rilmenidine, 3.3 mg)
Trial: 12386644
Drug: Low-profile infusion
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-profile infusion (total dose of rilmenidine, 1.45 mg)
Trial: 7748969
Drug: 4 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg/kg loading dose (LD) of gentamicin
Trial: 7748969
Drug: 2.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg/kg every 12, 18 or 24 h (control group)
Trial: 22367417
Drug: Citalopram plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram plus paliperidone (20 mg/day + 3 mg/day)
Trial: 15877299
Drug: Pravastatin 20
RxNorm normalized name: pravastatin 20 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin 20 mg/d
Trial: 24528686
Drug: Pravastatin 10
RxNorm normalized name: pravastatin 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin 10 mg/d
Trial: 11952433
Drug: Propofol infusion
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol infusion rate of 1.0 ml/s
Trial: 11952433
Drug: Propofol infusion
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol infusion rate of 0.2 ml/s
Trial: 7542473
Drug: Chemotherapy plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy plus interferon (IFN)
Trial: 2093956
Drug: Weekly interruption
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly interruption digoxin dosage (2 days interruption per week)
Trial: 2093956
Drug: Continuous digoxin
RxNorm normalized name: Digoxin
DrugBank: Digoxin (DB00390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuous digoxin dosage (uninterrupted)
Trial: 444354
Drug: Cinnarizine (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cinnarizine (75 mg) in capsule form
Trial: 444354
Drug: Cinnarizine (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cinnarizine (75 mg) in tablet form
Trial: 444354
Drug: Cinnarizine (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cinnarizine (75 mg)
Trial: 30602032
Drug: Denosumab 60
RxNorm normalized name: denosumab 60 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Denosumab 60 mg every 2 months
Trial: 26430694
Drug: Calcium supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium supplementation (1000 mg/day, four doses of 625 mg calcium carbonate for 1 month)
Trial: 24219374
Drug: Iron-fortified flavored
RxNorm normalized name: blackberry flavor
DrugBank: Blackberry (DB10628)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron-fortified flavored skim milk (500 mL/day)
Trial: 24219374
Drug: Iron and
RxNorm normalized name: beef,iron and wine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron and vitamin D-fortified flavored skim milk (500 mL/day)
Trial: 22517917
Drug: SPARX (computerised
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SPARX (computerised cognitive behavioural therapy)
Trial: 22517917
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual (face to face counselling)
Trial: 17598698
Drug: Commercially available
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Commercially available original preparation (reference)
Trial: 15510930
Drug: Premelle (Premarin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Premelle (Premarin 0.625 mg plus medroxyprogesterone acetate 2.5 mg/tablet orally)
Trial: 8301442
Drug: 2.5 ml/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 ml/kg surfactant
Trial: 8301442
Drug: 5.0 ml/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5.0 ml/kg surfactant
Trial: 8301442
Drug: Air placebo
RxNorm normalized name: air
DrugBank: Medical air (DB09337)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Air placebo (5.0 ml/kg)
Trial: 8301442
Drug: Standard two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard two 5.0 ml/kg rescue doses
Trial: 30089410
Drug: Carnosine supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carnosine supplementation (500 mg daily for two months)
Trial: 25439118
Drug: Intravenous self‐controlled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous self‐controlled analgesia (IA group, n = 24)
Trial: 25439118
Drug: Intravenous self‐controlled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous self‐controlled analgesia (IA group)
Trial: 8457308
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for cupulolithiasis
Trial: 8457308
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for canalithiasis
Trial: 17135854
Drug: Intervention cohort
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intervention cohort (n = 67) with lipid medication change during CR.
Trial: 17135854
Drug: Control cohort
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control cohort (n = 178) with lipid medication change during CR.
Trial: 12627040
Drug: Soy protein
RxNorm normalized name: Soy Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy protein with a medium dose of isoflavones (42 mg/day)
Trial: 12627040
Drug: Soy protein
RxNorm normalized name: Soy Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy protein with a higher dose of isoflavones (58 mg/day)
Trial: 15064585
Drug: r-hEPO administration
RxNorm normalized name: pantolactone, (R)-
FDA approved: no
EMA approved: no
PMDA approved: no
Description: r-hEPO administration
Trial: 11394604
Drug: Intraarticular morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraarticular morphine (5 mg)
Trial: 7993153
Drug: Intranasal fluticasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal fluticasone propionate (200 micrograms once daily)
Trial: 8655886
Drug: Terfenadine tablets
RxNorm normalized name: terfenadine Oral Tablet
DrugBank: Terfenadine (DB00342)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Terfenadine tablets (60 mg twice daily)
Trial: 18688547
Drug: 25 mg/week
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg/week iron supplement
Trial: 15246630
Drug: HPV16 L1
RxNorm normalized name: L1 protein, human papillomavirus type 11 vaccine
DrugBank: Human papillomavirus type 11 L1 capsid protein antigen (DB10300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HPV16 L1 virus-like particle vaccine
Trial: 11704601
Drug: Inhaled steroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled steroids alone or associated with oral steroids
Trial: 11704601
Drug: Steroid-untreated asthmatics
RxNorm normalized name: trimethylsilyl treated diimethiconol-trimethylsiloxysilicate crosspolymer (45-55 WW)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid-untreated asthmatics
Trial: 19317886
Drug: LEV XR
RxNorm normalized name: guaifenesin / hydrocodone bitartrate / phenylephrine hydrochloride Oral Solution [Uni-Lev 5.0]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LEV XR 1,000 mg/day
Trial: 3898835
Drug: Antacid given
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antacid given hourly
Trial: 15972451
Drug: Aspirin (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (150 mg/day) for hypercholesterolemics
Trial: 12485551
Drug: Delayed antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed antibiotic prescriptions
Trial: 25432415
Drug: Simvastatin 20
RxNorm normalized name: simvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 20 mg/extended-release (ER) niacin 2 g/day
Trial: 25432415
Drug: Fenofibric acid
RxNorm normalized name: Fenofibric Acid
DrugBank: Fenofibric acid (DB13873)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenofibric acid 135 mg
Trial: 30353590
Drug: 75 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 g/kg S‐DDGS
Trial: 30353590
Drug: 150 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 g/kg S‐DDGS
Trial: 30353590
Drug: 225 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 225 g/kg S‐DDGS
Trial: 30353590
Drug: 300 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 g/kg S‐DDGS
Trial: 30353590
Drug: 0 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 g/kg S‐DDGS (control)
Trial: 22967500
Drug: Saline infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline infusion (7-hour duration)
Trial: 15937294
Drug: Infliximab (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infliximab (5 mg/kg) administered via three infusions at Weeks 0, 2, and 6
Trial: 20523253
Drug: diazepam 10
RxNorm normalized name: diazepam 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: diazepam 10 mg
Trial: 30429050
Drug: Phased withdrawal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phased withdrawal of heart failure medications
Trial: 30429050
Drug: Continuation of
RxNorm normalized name: varenicline
DrugBank: Varenicline (DB01273)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuation of heart failure medications
Trial: 24223328
Drug: Lidocaine spray
RxNorm normalized name: lidocaine Mucosal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine spray (2 mg/kg)
Trial: 24223328
Drug: Morphine spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine spray (0.05 mg/kg)
Trial: 24223328
Drug: Ketamine spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine spray (0.5 mg/kg)
Trial: 24223328
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline spray (8 puffs)
Trial: 17961392
Drug: Glucosamine hydrochloride
RxNorm normalized name: Glucosamine Hydrochloride
DrugBank: Glucosamine (DB01296)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glucosamine hydrochloride (2 times daily for 6 weeks, 1 capsule each time)
Trial: 17961392
Drug: Glucosamine sulfate
RxNorm normalized name: Glucosamine Sulfate
DrugBank: Glucosamine (DB01296)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glucosamine sulfate (3 times daily for 6 weeks, 2 capsules each time)
Trial: 15628826
Drug: rasagiline 1
RxNorm normalized name: rasagiline 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rasagiline 1 mg
Trial: 15628826
Drug: rasagiline 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rasagiline 5 mg
Trial: 15628826
Drug: rasagiline 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rasagiline 10 mg
Trial: 31613432
Drug: Usual oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual oxygen therapy
Trial: 31227278
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment for 8 weeks
Trial: 31227278
Drug: Daily subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily subcutaneous 0.20-μg Teriparatide injection for 8 weeks (after 8 weeks of no treatment)
Trial: 31227278
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment for 8 weeks (followed by Teriparatide treatment)
Trial: 27665293
Drug: All treatments
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All treatments (NFB, MPH, PA)
Trial: 23520220
Drug: Cognitive-behavioural therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioural therapy (CBT) intervention for anger management, delivered over 12 weeks
Trial: 23520220
Drug: Cognitive-behavioural therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioural therapy (CBT) intervention for anger management
Trial: 21368386
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid 5 mg/d
Trial: 16260422
Drug: L-thyroxine substitution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-thyroxine substitution in hypothyroid patients
Trial: 9799029
Drug: Potassium supplementation
RxNorm normalized name: Potassium
DrugBank: Potassium (DB14500)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Potassium supplementation (64 mmol/day of K as slow-release KCl tablets)
Trial: 2793707
Drug: Almitrine (A)
RxNorm normalized name: almitrine
DrugBank: Almitrine (DB01430)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Almitrine (A) 75 mg po
Trial: 367713
Drug: Fenbufen 600
RxNorm normalized name: fenbufen 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenbufen 600 mg daily
Trial: 7495975
Drug: High-purity factor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-purity factor VIII preparations (ion-exchange S/D step)
Trial: 7495975
Drug: Monoclonal antibody
RxNorm normalized name: Monoclonal antibody
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monoclonal antibody factor VIII preparations
Trial: 12085255
Drug: Aspirin use
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin use (three or more times per week for at least 6 months)
Trial: 7900613
Drug: No aspirin
RxNorm normalized name: XS No Aspirin PR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No aspirin use
Trial: 2132273
Drug: 1.5% oral
RxNorm normalized name: Baro-Cat, 1.5% oral suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5% oral benzydamine spray applied six times per day (four sprays per application) for five days
Trial: 24494277
Drug: Acupuncture combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture combined with auricular point sticking therapy (group A)
Trial: 24494277
Drug: Clomiphene oral
RxNorm normalized name: clomiphene Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clomiphene oral administration (group B)
Trial: 1854430
Drug: Specific immunotherapy
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific immunotherapy using the alpha-fraction of D. pteronyssinus
Trial: 28802882
Drug: Ketamine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine infusion (0.05 mg/kg)
Trial: 28802882
Drug: Ketamine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine infusion (0.05 mg/kg) in opioid-naive subjects
Trial: 24114969
Drug: Fluticasone furoate/vilanterol
RxNorm normalized name: fluticasone furoate/vilanterol 100/25 MCG/INHAL Dry Powder Inhaler, 30 Blisters
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluticasone furoate/vilanterol (FF/VI) 100/25 μg once daily
Trial: 23846316
Drug: Fluticasone propionate/salmeterol
RxNorm normalized name: fluticasone propionate/salmeterol 100/50 MCG/INHAL Dry Powder Inhaler, 14 Blisters
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluticasone propionate/salmeterol (FP/SAL) 250/50 μg bid
Trial: 11684212
Drug: Hypertonic saline
RxNorm normalized name: ENTSOL Hypertonic Saline Nasal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypertonic saline (5 mL 7%)
Trial: 11684212
Drug: Daily rhDNase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily rhDNase vs Hypertonic saline
Trial: 11684212
Drug: Daily rhDNase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily rhDNase vs Alternate-day rhDNase
Trial: 24053480
Drug: Rosuvastatin 5
RxNorm normalized name: rosuvastatin 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin 5 mg/day (dose escalation group)
Trial: 21631570
Drug: Repaglinide (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repaglinide (1 mg, three times daily) for 8 weeks
Trial: 16412157
Drug: Zolmitriptan 2.5
RxNorm normalized name: zolmitriptan 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolmitriptan 2.5 mg
Trial: 8645847
Drug: Amphotericin B
RxNorm normalized name: Amphotericin B
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amphotericin B bladder irrigation (AmBBI) at 50 mg/L over 24 hours or 50 mg/L for 7 days
Trial: 8645847
Drug: Oral fluconazole
RxNorm normalized name: Fluconazole
DrugBank: Fluconazole (DB00196)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral fluconazole at 200 mg/d for 7 days
Trial: 2140996
Drug: Nafarelin 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nafarelin 400 micrograms daily
Trial: 2140996
Drug: Danazol 600
RxNorm normalized name: Danazol
DrugBank: Danazol (DB01406)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Danazol 600 mg daily
Trial: 31600790
Drug: Control cohort
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control cohort (standard treatment)
Trial: 30408001
Drug: Hexavalent vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hexavalent vaccine (DTaP‐IPV‐HB‐PRP‐T) at 2 and 6 months, Pentavalent vaccine (DTaP‐IPV//PRP‐T) at 4 months
Trial: 15271102
Drug: Continuous vancomycin
RxNorm normalized name: Vancomycin
DrugBank: Vancomycin (DB00512)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuous vancomycin infusion (CVI)
Trial: 15271102
Drug: Intermittent vancomycin
RxNorm normalized name: Vancomycin
DrugBank: Vancomycin (DB00512)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intermittent vancomycin infusion (IVI)
Trial: 19564877
Drug: diethylpropion 50
RxNorm normalized name: diethylpropion 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: diethylpropion 50 mg BID
Trial: 30192695
Drug: Ubiquinol (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ubiquinol (150 mg/day)
Trial: 23426761
Drug: Ketoconazole 400
RxNorm normalized name: ketoconazole 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoconazole 400 mg QD for 28 days
Trial: 21420111
Drug: Tanezumab (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tanezumab (200 μg/kg, single intravenous dose)
Trial: 27355532
Drug: Control (rabies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (rabies vaccine)
Trial: 8295879
Drug: pirazinamid administered
RxNorm normalized name: Pirazinamide
DrugBank: Pyrazinamide (DB00339)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: pirazinamid administered at a single dose daily or each other day
Trial: 3726454
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of neurotensin in relevant doses
Trial: 2568849
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of atracurium 0.125 mg kg‐1 + vecuronium 0.025 mg kg‐1
Trial: 28868633
Drug: Low‐to‐medium‐potency topical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low‐to‐medium‐potency topical corticosteroids (TCS)
Trial: 27108464
Drug: Combined spinal-epidural
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined spinal-epidural (CSE) with 0.5% heavy bupivacaine 2.5 mg
Trial: 27108464
Drug: Low-dose epidural
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose epidural
Trial: 23958597
Drug: High protein
RxNorm normalized name: Vital High Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High protein diet (30% protein [110 g/day], 40% carbohydrates [150 g/day], 30% fat [50 g/day])
Trial: 23958597
Drug: Standard protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard protein diet (15% protein [55 g/day], 55% carbohydrates [200 g/day], 30% fat [50 g/day])
Trial: 19702089
Drug: Ginkgo leaf
RxNorm normalized name: Ginkgo leaf
DrugBank: Ginkgo biloba (DB01381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginkgo leaf tablet (19.2 mg)
Trial: 16849753
Drug: Placebo (PL)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (PL) - orally, twice daily for 6 weeks
Trial: 15262604
Drug: 8 microg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 microg/kg intrathecal morphine sulfate
Trial: 8468114
Drug: Amikacin once
RxNorm normalized name: Amikacin
DrugBank: Amikacin (DB00479)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Amikacin once daily (single injection)
Trial: 8468114
Drug: Amikacin twice
RxNorm normalized name: Amikacin
DrugBank: Amikacin (DB00479)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Amikacin twice daily (two injections at 12-hour interval)
Trial: 23801529
Drug: lisdexamfetamine (30,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lisdexamfetamine (30, 50 or 70 mg/day)
Trial: 23801529
Drug: OROS-MPH (18,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OROS-MPH (18, 36 or 54 mg/day)
Trial: 15945502
Drug: Inhaled beta2-agonists,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled beta2-agonists, beclomethasone, disodiumcromoglycate, and immunotherapy (for 14 patients in group a and 28 patients in group b)
Trial: 15945502
Drug: Inhaled beta2-agonists,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled beta2-agonists, beclomethasone, disodiumcromoglycate (without immunotherapy for 14 patients in group c)
Trial: 2523664
Drug: Isradipine (0.5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isradipine (0.5, 1.25, or 2.5 mg twice daily)
Trial: 2897299
Drug: Propranolol (240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (240 mg)
Trial: 951465
Drug: Oxprenolol (320
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxprenolol (320 mg)